Zimmermann, Annamaria H.
Heidelberg University · Azienda Ospedaliera San Camillo-Forlanini · University Medical Center Hamburg-Eppendorf · Azienda Ospedaliera S.Giuseppe Moscati · Institutul Oncologic Bucuresti · Carlo Forlanini Hospital · Hospital Universitario Virgen del Rocío
2 papers on CoChat
Most cited papers
- Verified
PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Paz-Ares, L. G., de Marinis, F., Dediu, M., Thomas, M., Pujol, J.-L., Bidoli, P., Molinier, O., Sahoo, T. P., Laack, E., Reck, M., et al. (2013) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 624
- Verified
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
Paz-Ares, L., de Marinis, F., Dediu, M., Thomas, M., Pujol, J.-L., Bidoli, P., Molinier, O., Sahoo, T. P., Laack, E., Reck, M., et al. (2012) · The Lancet Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 610
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free